HuidaGene Therapeutics (HuidaGene), a global clinical─stage biotechnology company developing genome medicines, announced that the US FDA has cleared...

THURSDAY, Nov. 7, 2024 -- More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal...

Results provide first evidence of biological and clinical effect of a mid-domain tau-targeting disease-modifying therapy1 In full study population...

Scientists in the East of England have developed a way of using artificial intelligence to check for skin cancer, with the AI tool outperforming...

Pregnant women are typically excluded from clinical trials of new TB medicines. This has led to a lack of solid scientific evidence on how best to...

A recent Italian study suggests that eating a lot of ultra-processed foods may be speeding up biological aging, regardless of the nutritional quality...

Tashkent: Uzbekistan's foreign trade turnover with the US reached $672.2 million from January through September 2024. Data obtained by Trend from the...

Donald Trump's Truth Social platform may have its future as a viable — yet money-losing — site impacted now that the former president is headed...

The ASX plunged after supermarket stocks slumped on a Woolies warning; and GCM ticker surges 200pc on graphite tech deal. ...

A study by German research institute Fraunhofer ISE has revealed a troubling trend. Data shows that modules are increasingly attributed higher power...